Low molecular weight fucoidan ameliorates hindlimb ischemic injury in type 2 diabetic rats
- 14 September 2017
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 210, 434-442
- https://doi.org/10.1016/j.jep.2017.09.014
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation (81370339, 81570206)
- Beijing Innovation Promoting Project (TJSHG201510025005)
This publication has 36 references indexed in Scilit:
- Modulation of platelet aggregation-related eicosanoid production by dietary F-fucoidan from brown algaLaminaria japonicain human subjectsBritish Journal of Nutrition, 2013
- Therapeutic effect of fucoidan‐stimulated endothelial colony‐forming cells in peripheral ischemiaJournal of Thrombosis and Haemostasis, 2012
- Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulationCardiovascular Diabetology, 2009
- The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestineBiomaterials, 2008
- Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exerciseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Impaired Angiogenesis After Hindlimb Ischemia in Type 2 Diabetes MellitusCirculation Research, 2007
- Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia After Aortic AllograftingTransplantation, 2007
- Cellular and molecular basis of wound healing in diabetesJCI Insight, 2007
- A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweedsGlycobiology, 2007
- Vascular Endothelial Growth Factor and AngiogenesisPharmacological Reviews, 2004